Lynda Doward, MRes, is the European Head of Patient-Centered Outcomes Assessment (PCOA) at RTI-HS. Ms. Doward has over 30 years of experience in PCOA research. She provides advice and guidance to pharmaceutical companies, medical personnel, and academic researchers on the incorporation of PCOA and health-utility measurement into pharmaceutical product development strategies, clinical trial design and questionnaire development, translation, adaptation, and validation. Ms. Doward has particular expertise in research design and in the application of both traditional and innovative qualitative and quantitative research methods. She has extensive experience managing large-scale international projects involving a broad range of therapeutic areas. Ms. Doward was a Lead Member of an International Benefit Assessment Taskforce for Outcome Measurement in Multiple Sclerosis from 2004 to 2009, has acted as a consultant to the World Health Organization and has served as a Research Advisor to the UK Department of Health, and the Arthritis Research Campaign. Ms. Doward has published widely in peer-reviewed journals, has presented her research at numerous international symposia, and acts as Peer Reviewer for Value in Health, Pharmacoeconomics, Quality of Life Research, and several other journals.